SIETES :: 92565 citas

Añadir las seleccionadas a mis citas; si se ha deseleccionado alguna, se eliminara de mis citas

Actualizar mis citas con la selección

1 a 20 de 562 siguiente >>

Presentar resultados

Seleccionar todas

1.

Cita con resumen

Anónimo. Hallucinations and pimavanserin (NUPLAZID), a new kind of drug for psychosis. ISMP Quarter Watch 2018:6. [Ref.ID 102509]

2.

Cita con resumen

Wise J. Stent trial researchers are accused of changing endpoints to suit results. BMJ 2018;360:k1298. [Ref.ID 102477]

3.

Cita con resumen

Anónimo. Senate investigation reveals five manufacturers funded groups that acted as opioid “cheerleaders.”. DIA Daily 2018:12. [Ref.ID 102455]

4.

Cita con resumen

Silverman E. Sanofi scandal in the Philippines could spread dangerous mistrust of vaccines. STAT Daily Recap 2017:2. [Ref.ID 102176]

5.

Enlace a cita original

Cita con resumen

Mershon E. STAT Plus: Drug makers dodged $1.3 billion in payments to Medicaid, report finds. STAT Daily Recap 2017:20 de diciembre. [Ref.ID 102173]

6.

Tiene citas relacionadas

Cita con resumen

Silverman E. Sanofi scandal in the Philippines could spread dangerous mistrust of vaccines. STAT 2017:1. [Ref.ID 102167]

7.

Cita con resumen

Anónimo. FDA analysis shows many pharmaceutical makers’ post-marketing studies still pending. DIA Daily 2017:11. [Ref.ID 102164]

8.

Cita con resumen

Anónimo. Whistleblower lawsuit claims AstraZeneca knew of deadly risk of drug interaction. DIA Daily 2017:13. [Ref.ID 102162]

9.

Cita con resumen

Anónimo. Canadian report says drug industry failing to meet R&D investment pledge. DIA Daily 2017:9. [Ref.ID 102160]

10.

Cita con resumen

Anónimo. Former Insys CEO arrested and charged with conspiracy, racketeering for marketing and sales of fentanyl. DIA Daily 2017:2. [Ref.ID 102102]

11.

Cita con resumen

Healy D. Antidepressants and murder: justice denied. BMJ 2017;358:j4196. [Ref.ID 102086]

12.

Cita con resumen

Batelaan NM, Bosman RC, Muntingh A, Scholten WD, Huijbregts KM, van Balkom AJLM. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. BMJ 2017;358:j3927. [Ref.ID 102068]

13.

Tiene citas relacionadas

Cita con resumen

Anónimo. Insys Therapeutics faked cancer diagnoses to sell more of its opioid medication, senator says. DIA Daily 2017:11. [Ref.ID 102048]

14.

Tiene citas relacionadas

Cita con resumen

Anónimo. Insys ignored warnings, manipulated marketing of fentanyl, investigation suggests. DIA Daily 2017:1. [Ref.ID 102046]

15.

Tiene citas relacionadas

Cita con resumen

Anónimo. Novo Nordisk to pay $58.7 million to settle US probe over diabetes drug liraglutide. DIA Daily 2017:1. [Ref.ID 102045]

16.

Cita con resumen

Becker WC, Fiellin DA. Limited evidence, faulty reasoning, and potential for a global opioid crisis. BMJ 2017;358:j3115. [Ref.ID 102015]

17.

Cita con resumen

de Boissieu P, Kanagaratnam L, Mahmoudi R, Morel A, Dramé M, Trenque T. Adjudication of osteonecrosis of the jaw in phase III randomized controlled trials of denosumab: a systematic review. Eur J Clin Pharmacol 2017;73:517-23. [Ref.ID 101992]

18.

Cita con resumen

Ebell MH. WHO downgrades status of oseltamivir. BMJ 2017;358:j3266. [Ref.ID 101981]

19.

Cita con resumen

Rosenberg HG, Shnier A. Regulatory data are hidden in plain sight. BMJ 2017;358:j3437. [Ref.ID 101980]

20.

Cita con resumen

Silverman E. US drug regulators should consider adding adults to SSRI suicide warning, says campaigner. BMJ 2017;357:j2050. [Ref.ID 101550]

Seleccionar todas

Añadir las seleccionadas a mis citas; si se ha deseleccionado alguna, se eliminara de mis citas

Actualizar mis citas con la selección

1 a 20 de 562 siguiente >>